Albert Einstein College of Medicine has received a five-year, $10.8 million grant from the National Institutes of Health (NIH) to create the New York Regional Diabetes Research Center (NYR-DRC), a newly expanded multi-institutional center co-led with the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine. The center will focus on discovering scientific knowledge and translating it into improved care for people with diabetes and related metabolic diseases.

A first-of-its-kind study explored whether more accessible technologies – foot-mounted wearable sensors and a 3D depth camera – could accurately measure how people walk, offering a practical alternative to traditional gait analysis tools. Gait, or walking pattern, is a key health indicator used to detect fall risk, monitor rehabilitation and identify early signs of conditions like Parkinson’s and Alzheimer’s. Traditional systems like the Zeno™ Walkway, the gold standard for gait analysis, are accurate but expensive, bulky and not easily used outside of lab settings.

High levels of a specific protein can reduce the growth of tumour cells in neuroblastoma, a form of cancer that affects the sympathetic nervous system in young children. This is shown in a new study by researchers at Umeå University and Karolinska Institutet, Sweden. The protein in question also seems to cause the cancer cells to change into less aggressive cells

The Mount Sinai Health System has appointed Bethany Slater, MD, MBA, as Division Chief of Pediatric Surgery at Mount Sinai Kravis Children’s Hospital and Associate Professor of Surgery and Pediatrics at the Icahn School of Medicine at Mount Sinai, effective Wednesday, October 1.